Back

BioCryst Pharmaceuticals Stock Predictions

7 Stocks to Buy and Hold Forever

The result is a select group of high-quality blue-chip stocks.

Buy

BCRX
BioCryst Pharmaceuticals

Last Price:

$10.40

Seasonality Move:

26.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Sleep well at night with 7 stellar stocks to buy and hold forever

Get the complete list FREE for a limited time.

BioCryst Pharmaceuticals Stock Forecast

Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 40.9% based on the past 31 years of stock performance.
BioCryst Pharmaceuticals has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%
Is BioCryst Pharmaceuticals Stock Undervalued?

The current BioCryst Pharmaceuticals [BCRX] share price is $10.40. The Score for BCRX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
BCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will BioCryst Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 40.9% based on the past 31 years of stock performance.

BioCryst Pharmaceuticals Stock Rating

Buy

BioCryst Pharmaceuticals (BCRX) is a Buy

Is BioCryst Pharmaceuticals overpriced?

BioCryst Pharmaceuticals has risen higher in 16 of those 31 years over the subsequent 52-week period, corresponding to a historical accuracy of 51.61%

BioCryst Pharmaceuticals Stock Price History

Is BCRX stock going to rise?

The current trend is moderately bearish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

biocryst.com

52-Week Data

52-Week High:

11.31

52-Week Low:

5.92

Prediction Charts

Market Cap:

2.2B

Price in USD:

10.40

Volume:

3.8M

Beta:

1.68

Technical Analysis

SMA50:

9.24

SMA100:

8.68

SMA200:

8.20

52-Wk Change:

65.08%

Stock Predictions

Is BioCryst Pharmaceuticals stock public?

Yes, BioCryst Pharmaceuticals is a publicly traded company.
What is the BioCryst Pharmaceuticals stock quote today?

The BioCryst Pharmaceuticals stock price is 10.40 USD today.
How to buy BioCryst Pharmaceuticals stock online?

You can buy BioCryst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-23	10.29	10.59	10.59	10.16
May-27	10.92	10.79	11.03	10.58
May-28	10.68	10.56	10.81	10.55
May-29	10.62	10.88	11.00	10.46
May-30	10.85	10.75	10.88	10.62
Jun-2	10.79	10.73	11.15	10.69
Jun-3	10.65	11.19	11.24	10.51
Jun-4	11.23	11.04	11.31	11.00
Jun-5	11.01	10.98	11.11	10.90
Jun-6	11.06	11.04	11.18	10.88
Jun-9	11.20	11.11	11.23	10.97
Jun-10	11.06	11.01	11.22	10.98
Jun-11	11.06	10.61	11.07	10.59
Jun-12	10.55	10.40	10.64	10.34

BioCryst Pharmaceuticals Earnings

BioCryst Pharmaceuticals Earnings Report: Per Share BioCryst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

BioCryst Pharmaceuticals Forecast Revenue Growth

BioCryst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.09 per share, an increase this year of $0.55 per share, and an increase next year of $0.33 per share.

* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.